Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Anesteziol Reanimatol ; (4): 10-5, 2009.
Artigo em Russo | MEDLINE | ID: mdl-19824410

RESUMO

Sixty patients who had undergone cardiosurgical operations under extracorporeal circulation (EC) were enrolled in the study. All the patients were divided into 2 groups: (1) 40 patients were injected tranexamic acid (TA) (its loading dose was 15 mg/kg; maintenance infusion 1 mg/kg/h throughout the operation; 500 mg in the primary packing volume for an EC apparatus (EA); (2) 20 patients received epsilon-aminocapronic acid (ACA) (its loading dose was 5 g; 5 g in the primary packing volume for an EA and 10 g for infusion after EC). The effects of TA and ACA on the fibrinolytic system were evaluated from the time of XIIa-kallikrein-dependent fibrinolysis (sec) and the concentration of D-dimer (mg/ml). The hemocoagulation system (activated partial thromboplastin time, thrombin clotting time, prothrombin time with the determination of the international normalized ratio, fibrinogen) was studied. The thromboelastogram (the time R, K, and alpha-angle, MA) was analyzed. The indices were determined at the beginning and end of, and 12 hours after surgery. The analysis of the clinical efficacy and safety of the agents was based on the following perioperative data: the incidence of adverse reactions and complications associated with the administration of the agents, the frequency and amount of transfused donor blood components, the volume of blood loss, and the rate of resternotomies. The laboratory and clinical findings lead to the conclusion that TA (Tranexam, OOO "MIR-PHARM") has a 4-fold antifibrinolytic activity as compared with epsilon-ACA. The more pronounced TA-induced suppression of fibrinolysis affects the clinical course of a perioperative period in this group, which manifests itself as a reduced blood loss volume during and after surgery and a lower frequency of use of donor blood elements. By taking into account these data, TA may be recommended as one of the blood-preserving technology components during cardiosurgical operations under EC.


Assuntos
Ácido Aminocaproico/uso terapêutico , Antifibrinolíticos/uso terapêutico , Circulação Extracorpórea , Cardiopatias/cirurgia , Ácido Tranexâmico/uso terapêutico , Idoso , Ácido Aminocaproico/administração & dosagem , Ácido Aminocaproico/efeitos adversos , Anestesia Geral , Antifibrinolíticos/administração & dosagem , Antifibrinolíticos/efeitos adversos , Coagulação Sanguínea/efeitos dos fármacos , Perda Sanguínea Cirúrgica/prevenção & controle , Circulação Extracorpórea/efeitos adversos , Feminino , Cardiopatias/sangue , Hemostasia Cirúrgica/métodos , Humanos , Masculino , Ácido Tranexâmico/administração & dosagem , Ácido Tranexâmico/efeitos adversos
2.
Klin Lab Diagn ; (2): 24, 33-5, 2008 Feb.
Artigo em Russo | MEDLINE | ID: mdl-18354918

RESUMO

The paper gives the data of comparing the use of various formulas to calculate glomerular filtration rate (GFR) for the evaluation of postoperative renal function in cardiosurgical patients. GFR is shown to evaluate renal filterability with a high degree of reliability. Monitoring of GFR changes may characterize the progression of renal diseases. This indicator is an important predictor of the onset of renal insufficiency and the risk of complications due to chronic renal disease. Calculation of GFR in clinical practice enables the agents excreted owing to glomerular filtration to be dosed to prevent their potential toxicity.


Assuntos
Taxa de Filtração Glomerular , Cardiopatias/fisiopatologia , Feminino , Cardiopatias/cirurgia , Humanos , Falência Renal Crônica/diagnóstico , Falência Renal Crônica/fisiopatologia , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/fisiopatologia , Período Pós-Operatório
3.
Klin Lab Diagn ; (3): 44-6, 2008 Mar.
Artigo em Russo | MEDLINE | ID: mdl-18450083

RESUMO

The paper presents data on comparison of the detection rate of renal dysfunction after cardiac surgery, by using the criteria developed by Cockroft-Gault, C. M. Mangano, L.-G. Andersson, and G. Zanardo. It is shown that it is expedient to calculate creatinine phosphokinase by the Cochroft-Gault formula that using a patient's individual parameters provides a more objective approach to making the diagnosis of renal dysfunction. The rate of development of renal dysfunctions in patients who have undergone cardiac surgery under extracorporeal circulation (EC) depends on the type of an operation and the duration and temperature of perfusion. By postoperative day 14, renal function became normal in the vast majority of patients. Renal function became chronic in 1% of the patients operated on the heart under EC.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Circulação Extracorpórea , Nefropatias/diagnóstico , Complicações Pós-Operatórias/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Nefropatias/etiologia , Masculino , Período Pós-Operatório
4.
Patol Fiziol Eksp Ter ; (3): 23-6, 2008.
Artigo em Russo | MEDLINE | ID: mdl-18942472

RESUMO

Normothermic artificial circulation, irrespective of its duration, enhances erythrocyte aggregation in response to noradrenaline stimulation. Short-term hypothermic perfusion reduces adrenergic aggregation of erythrocytes while in long-term hypothermic artificial circulation changes in erythrocyte adrenergic aggregation are not significant. In the course of cardiosurgical operation in conditions of artificial circulation adrenergic erythrocyte aggregation undergoes changes: a maximal rise before perfusion, linear lowering and rise to the preoperative level. If perfusion lasts longer than 90 min adrenergic aggregation of erythrocytes sharply and significantly falls. This aggregation depends little on hematocrit, but if it falls under 15% aggregation becomes significant which may be of importance in blood loss arrest in massive blood loss, hemodilution, dilution of coagulation factors and marked thrombocytopenia. In such conditions erythrocyte aggregates may seal damaged microvessels acting as hemostatic lock.


Assuntos
Doenças Cardiovasculares/sangue , Agregação Eritrocítica , Circulação Extracorpórea , Fatores de Coagulação Sanguínea/análise , Perda Sanguínea Cirúrgica/fisiopatologia , Doenças Cardiovasculares/fisiopatologia , Doenças Cardiovasculares/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo
5.
Khirurgiia (Mosk) ; (8): 17-20, 2007.
Artigo em Russo | MEDLINE | ID: mdl-17828120

RESUMO

Effects of different doses and lots of protamine sulfate on hemostasis system after cardiac operations with artificial circulation are analyzed. Overall 982 patients underwent cardiac operations with artificial circulation. Quality and purity of protamine may be the causes of side effects. Negative effect of high doses of protamine on hemostasis system is demonstrated. Thrombocyte dysfunction is the main cause of intensive postoperative bleeding after administration of protamine high doses.


Assuntos
Procedimentos Cirúrgicos Cardíacos/métodos , Circulação Extracorpórea/métodos , Antagonistas de Heparina/farmacologia , Protaminas/farmacologia , Trombocitopenia/prevenção & controle , Esquema de Medicação , Hemostasia Cirúrgica , Antagonistas de Heparina/uso terapêutico , Humanos , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Protaminas/uso terapêutico , Trombocitopenia/epidemiologia , Trombocitopenia/etiologia
6.
Klin Lab Diagn ; (5): 28-9, 2007 May.
Artigo em Russo | MEDLINE | ID: mdl-17665617

RESUMO

The paper describes a method for calculating the additional dose of protamine sulfate solution during incomplete heparin neutralization after cardiac surgery under extracorporeal circulation, by estimating the anti-Xa-activity of venous blood plasma. The method may be an alternative to the use of devices to measure the blood concentration of free heparin, such as a "Hepcon" apparatus.


Assuntos
Perda Sanguínea Cirúrgica/prevenção & controle , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Antagonistas de Heparina/administração & dosagem , Heparina/sangue , Protaminas/administração & dosagem , Coagulação Sanguínea , Ponte de Artéria Coronária/efeitos adversos , Circulação Extracorpórea/métodos , Fator Xa/análise , Inibidores do Fator Xa , Feminino , Doenças das Valvas Cardíacas/cirurgia , Implante de Prótese de Valva Cardíaca/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Valva Mitral , Cardiopatia Reumática/cirurgia
7.
Klin Lab Diagn ; (12): 15-7, 2007 Dec.
Artigo em Russo | MEDLINE | ID: mdl-18225508

RESUMO

Subclinically insignificant glomerular filtration disturbances were found during operations under extracorporeal circulation. After termination of perfusion, dysfunction of the proximal portion of renal tubules was recorded in all patients. This may be associated with that the proximal tubules were more susceptible to ischemia. Further impairments of the distal portions of renal tubules suggest the persistence of ischemic lesions of the tubular apparatus.


Assuntos
Ponte de Artéria Coronária , Circulação Extracorpórea/efeitos adversos , Complicações Intraoperatórias/diagnóstico , Nefropatias/diagnóstico , Glomérulos Renais/fisiopatologia , Túbulos Renais/fisiopatologia , Adulto , Feminino , Taxa de Filtração Glomerular , Humanos , Complicações Intraoperatórias/etiologia , Isquemia/complicações , Nefropatias/etiologia , Glomérulos Renais/irrigação sanguínea , Túbulos Renais/irrigação sanguínea , Masculino , Pessoa de Meia-Idade
8.
Vestn Ross Akad Med Nauk ; (12): 21-5, 2006.
Artigo em Russo | MEDLINE | ID: mdl-17784568

RESUMO

Recombinant activated factor VII was used in a dose of 30 to 140 mcgr/kg in 35 cardiosurgical patients during intra- and postoperative periods complicated by massive uncontrolled (5 to 25 ml/min) bleeding of non-surgical origin. Basing on the analysis of changes in the hemostasis system parameters, the mechanism of action of the preparation may be presented as follows: recombinant fVIIa forms a complex with TF at the site of lesion; the formation of TF-fVIIa complex leads to the appearance of small amount of synthesized thrombin on the membrane of TF-containing cells, which, in turn, activates thrombocytes at the site of lesion; thrombocytes excrete phosphatidylserine, which serves as a matrix for further thrombin formation. FXIII is expressed from a granules ofthrombocytes and gets activated. FXIII binds with a specific receptor on platelets' membrane. It remains active as enzyme and participates in the formation of a firm fibrin plug at the site of lesion. Besides, substances with pro- and antifibrinolytic activity, antiheparin factor 4 and fibronectin are released from alpha granules. Factors IXa, VIIIa, and Va effectively "attach" to the surface of activated thrombocytes, and the forming of IXa-VIIIa complex leads to further activation of factor X, which, together with factor 3 expression, facilitates further local thrombin generation.


Assuntos
Perda Sanguínea Cirúrgica/prevenção & controle , Fator VIIa/uso terapêutico , Cuidados Intraoperatórios/métodos , Cuidados Pós-Operatórios/métodos , Hemorragia Pós-Operatória/tratamento farmacológico , Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Relação Dose-Resposta a Droga , Fator VIIa/administração & dosagem , Fator XIII/metabolismo , Seguimentos , Hemostasia/efeitos dos fármacos , Humanos , Infusões Intravenosas , Tempo de Tromboplastina Parcial , Hemorragia Pós-Operatória/sangue , Tromboplastina/metabolismo , Resultado do Tratamento
9.
Angiol Sosud Khir ; 12(3): 21-7, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17641610

RESUMO

AIM: to examine hemostasis in patients undergoing carotid endarterectomy as dependent on the course of the short-term postoperative period. MATERIALS AND METHODS: altogether 36 patients who had undergone unilateral carotid endarterectomy (CEAE) were examined. Intraoperatively, all the patients received unfractionated heparin (UFH) in a dose of 80 - 100 IU/kg bw. As dependent on the course of the short-term postoperative period the patients were distributed into two groups: group 1 included 12 patients who developed disorders of cerebral circulation (DCC) within the first hours after operation, group 2 included 24 persons with no complications. Plasma-platelet hemostasis, the system of natural anticoagulants and fibrinolysis were examined before, at the end, 6 hours and on the first day after CEAE. RESULTS: prior to operation all the patients had no significant change in the hemostatic system. Toward the end of operation groups 1 and 2 did not differ in the basic parameters of the hemostatic system. Group showed a remarkable platelet hyperaggregation. Six hours after operation group 1 demonstrated significantly lower values of ACT, BCT, MHO, an appreciably higher value of APTT and pronounced inhibition of fibrinolytic activity associated with platelet hyperaggregation. On the first postoperative day group 1 retained a significantly lower value of BCT, showed a significant lowering of APTT as compared to the previous observation stages and comparatively to group 2, demonstrated a significantly lower activity of AT III and fibrinolysis. At this stage ADO-induced platelet aggregation in group 1 was appreciably higher than in group 2. Platelet hyperaggregation in group 1 patients appeared a first manifestation of consumption coagulopathy. The significantly higher value of APTT mirrored a compensatory output of endogenous heparin. On the first postoperative day group 1 demonstrated a remarkable consumption of endogenous heparin, noticeably lower activity of AT III, material XIIaKDF inhibition, and retained pronounced platelet hyperaggregation. CONCLUSION: the intensity and extent of the atherosclerotic process in the cerebral vessels together with platelet hyperaggregation lead to the rise of the thrombogenic potential and increase the risk of thrombogenic complications in the immediate hours following operation. Antiaggregation and anticoagulation therapy should be instituted in such patients in the preoperative period and resumed directly after operation.


Assuntos
Encéfalo/irrigação sanguínea , Estenose das Carótidas/fisiopatologia , Estenose das Carótidas/cirurgia , Endarterectomia das Carótidas/métodos , Complicações Pós-Operatórias , Trombocitose/diagnóstico , Trombocitose/etiologia , Circulação Cerebrovascular/fisiologia , Diagnóstico Precoce , Fibrinolíticos/uso terapêutico , Humanos , Coeficiente Internacional Normatizado , Tempo de Tromboplastina Parcial , Trombocitose/tratamento farmacológico
10.
Angiol Sosud Khir ; 12(2): 101-4, 2006.
Artigo em Russo | MEDLINE | ID: mdl-17053770

RESUMO

MATERIAL AND METHODS: A total of 24 patients were examined after surgery on the thoracic or abdominal aorta. Depending on the level of the aortic clamping at the main stage of the operation, the patients were subdivided into three groups: Group One was composed of 7 patients with aortic coarctation in whom the level of artery clamping was located just below the subclavian artery, Group Two comprised 7 patients with an aneurysm of the infrarenal aortic portion, with the clamp applied immediately underneath the renal arteries, and Group Three consisted of 10 patients with type IV thoracoabdominal aortic aneurysm according to Crawford's classification, with the artery being clamped above the diaphragm. The studies were carried out at the following stages: before and at the end of surgery, then 6 hours thereafter, and at 24 hours postoperatively. RESULTS: The alterations in the indices of plasma-thrombocytic haemostasis at all the stages were insignificant and did not differ reliably between the groups. In Group One patients, the time of XHa-kallikrein-dependent fibrinolysis (XIIaKDF) at the end of the operation was found to be within the range of the normal values(657.5+/-92.3 s) and had no statistically reliable differences from the baseline value (612.0+/-63.7 s). After 6 hours and on day 1 after the operation, we observed inconsiderable inhibition of the fibrinolytic activity (903.0+/-142.3 and 848.9+/-149.5 s, respectively). In Group Two patients at the end of the operation, we registered a statistically reliable, as compared with the baseline value, shortening of the time of XIIaKDF (from 990.0 +/-81.0 to 510.0 +/- 103.6 s, p<0.05). However, the subsequent stages of the follow-up revealed a dramatic decrease in the fibrinolytic activity (to1.388.0+/-183.1 s). Group Three patients demonstrated a considerable activation of fibrinolysis at the end of the operation (348.2 +/-48.5 s), which was noted to remain unchanged during the first 24 postoperative hours, with the alterations in the D-dimer's concentration in patients of all groups at the stages of observation being of a unidirectional pattern, i. e. increasing maximally after 6 hours to be then decreasing on the first 24 hours after the operation. CONCLUSION: To prevent postoperative haemorrhage associated with hyperfibrinolysis in aortic operations, it is necessary to administer antifibrinolytic drugs with due regard for the level of aortic clamping.


Assuntos
Doenças da Aorta/sangue , Doenças da Aorta/cirurgia , Hemostasia/fisiologia , Procedimentos Cirúrgicos Vasculares , Adulto , Aorta Abdominal , Aorta Torácica , Perda Sanguínea Cirúrgica/prevenção & controle , Feminino , Seguimentos , Humanos , Masculino , Prognóstico
11.
Khirurgiia (Mosk) ; (11): 14-7, 2006.
Artigo em Russo | MEDLINE | ID: mdl-17159870

RESUMO

It is demonstrated that special surface of extracorporeal circuit promotes reduction of artificial circulation negative influence on hemostasis system. During artificial circulation coating "duraflo" gradually loses its protective characteristics due to washout of heparin molecules from the surface of extracorporeal circuit, whereas chemical link between heparin and protein in "safe-line" coating is more stable. The results of the study demonstrate no advantages of heparin coating of extracorporeal circuits over protein one. Finally, all the advantages of extracorporeal circuits with "safe-line" coating lead to a decrease of postoperative blood loss.


Assuntos
Circulação Assistida/estatística & dados numéricos , Procedimentos Cirúrgicos Cardíacos/estatística & dados numéricos , Circulação Extracorpórea/estatística & dados numéricos , Hemostasia/fisiologia , Contagem de Células Sanguíneas , Plaquetas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
12.
Anesteziol Reanimatol ; (5): 31-3, 2006.
Artigo em Russo | MEDLINE | ID: mdl-17184058

RESUMO

The paper presents data of a study comparing two schemes (Scheme 1: a heparin/protamine ratio of 1:2; Scheme 2: a heparin/protamine ratio of 1:3) for administering protamine sulfate to neutralize heparin in patients after extracorporeal circulation. A larger dose of protamine sulfate is shown to induce significant thrombocytic dysfunction, resulting in increased postoperative hemorrhage. To minimize protamine sulfate doses required for neutralization of the anticoagulant effect of heparin is a way of preventing these complications.


Assuntos
Ponte de Artéria Coronária , Circulação Extracorpórea , Hemostasia/efeitos dos fármacos , Antagonistas de Heparina/administração & dosagem , Protaminas/administração & dosagem , Plaquetas/efeitos dos fármacos , Antagonistas de Heparina/efeitos adversos , Humanos , Cuidados Pós-Operatórios , Protaminas/efeitos adversos
13.
Vestn Ross Akad Med Nauk ; (10): 12-5, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16320700

RESUMO

The article contains data which demonstrate that use of extracorporal circuits with special coating ("safe-line" and "duraflow") improves preservation of thrombocyte functional activity, and lowers activation of the fibrinolysis system in postoperative period, which results in decrease of postoperative blood loss. Use of heat exchangers with polypropylene coating is less traumatic to blood cells, and thus lowers frequency and degree of hemolysis.


Assuntos
Plaquetas/fisiologia , Circulação Extracorpórea/instrumentação , Fibrinólise/fisiologia , Hemólise/fisiologia , Feminino , Hemostasia/fisiologia , Humanos , Nefropatias/fisiopatologia , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias
14.
Angiol Sosud Khir ; 11(3): 7-12, 2005.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-16439943

RESUMO

The lack of significant changes in the count and function of platelets in aortic surgery without use of cardiopulmonary bypass (CPB) confirms that factors of extracorporeal circulation exert a remarkable adverse action on the platelet component of hemostasis. In operations performed under hypothermic perfusion or circulatory arrest, disorders of the platelet component even in case of the use of 2 mln. CIU trasylol (aprotinin) are most pronounced which gives rise to excessive postoperative blood loss in the given patient group. It may be assumed that the increase of the dose of trasylol up to 6 mln. CIU will allow, owing to its cytoprotective action, preserve as well as possible the quantitative and qualitative properties of platelets.


Assuntos
Aneurisma Aórtico/cirurgia , Plaquetas/fisiologia , Hemostasia/fisiologia , Procedimentos Cirúrgicos Vasculares , Aneurisma Aórtico/sangue , Aprotinina/uso terapêutico , Seguimentos , Hemostáticos/uso terapêutico , Humanos , Agregação Plaquetária/efeitos dos fármacos , Agregação Plaquetária/fisiologia , Contagem de Plaquetas , Hemorragia Pós-Operatória/sangue , Hemorragia Pós-Operatória/prevenção & controle , Fatores de Tempo
15.
Angiol Sosud Khir ; 11(4): 27-31, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16474289

RESUMO

This paper describes hemostatic changes in patients who had undergone aortic surgery under conditions of extracorporeal circulation. The changes in the hemostatic system are marked by the thrombophilic condition made up for activation ox blood fibrinolytic activity in the preoperative period. The basic amount of blood loss falls within the first 6 hours after operation. Prolonged hypothermic extracorporeal circulation and the high intraoperative blood loss (over 35 ml/kg bw) lead to an appreciable decrease in antithrombin III and protein C activity which results in activation of disseminated intravascular blood coagulation in the early postoperative period and ineffectiveness of heparin therapy. Secondary hyperfibrinolysis together with combined thrombocytopenia and platelet dysfunction are the basic causes of higher than usual bleeding in patients after aortic surgery under conditions of extracorporeal circulation.


Assuntos
Aorta/cirurgia , Perda Sanguínea Cirúrgica , Circulação Extracorpórea , Hemostasia , Antitrombina III/análise , Aorta Torácica/cirurgia , Valva Aórtica/cirurgia , Plaquetas/fisiologia , Prótese Vascular , Feminino , Implante de Prótese de Valva Cardíaca , Humanos , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório , Proteína C/análise , Trombocitopenia/complicações , Fatores de Tempo
16.
Anesteziol Reanimatol ; (4): 58-60, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16206590

RESUMO

The paper presents the results of a retrospective study of small-dose (2,000,000 ECU) trasilol (Group 1) and aminocapronic acid (Group 2) on the size of postoperative blood loss in patients after cardiac surgery under extracorporeal circulation (EC). The mean postoperative blood loss was 4.7 +/- 0.2 and 4.8 +/- 0.4 ml/kg/day in Groups 1 and 2, respectively (p > 0.05). A significantly less blood loss was noted when trasilol was used in patients with normothermal prolonged EC as compared with hypothermal prolonged EC (p < 0.05), which may be associated not only with temperature conditions, but also with the significantly less mean duration of normothermal EC (113.1 +/- 3.4 and 136.9 +/- 6.0 min, respectively (p < 0.05). In Groups 1 and 2, postoperative blood loss after hypothermal prolonged EC did not differ significantly, the duration of EC being significantly higher in Group 1 patients than that in Group 2 (p < 0.02). This is indicative of the advantage of the use of trasilol in cases of prolonged hypothermal perfusion. The use of trasilol is preferable in patients with a large scope of surgical intervention under prolonged hypothermal perfusion. By taking into account the equal efficacy of trasilol and aminocapronic acid in reducing postoperative blood loss, the use of aminocapronic acid is more profitable.


Assuntos
Aminocaproatos/uso terapêutico , Antifibrinolíticos/uso terapêutico , Aprotinina/uso terapêutico , Ponte de Artéria Coronária , Circulação Extracorpórea , Hemorragia Pós-Operatória/prevenção & controle , Aminocaproatos/administração & dosagem , Antifibrinolíticos/administração & dosagem , Aprotinina/administração & dosagem , Esquema de Medicação , Feminino , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
18.
Anesteziol Reanimatol ; (2): 30-2, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15206273

RESUMO

The paper contains the results of a retrospective analysis of causes for an intensified bleeding in patients operated on the heart with artificial blood circulation. An affected hemostasis plasma chain, i.e. insufficiency of blood coagulation factors due to hemodelution, hypofibrinogenemia etc., provoked the above disorder in 39% of patients with a higher postoperative bleeding. Additional reasons for the impaired hemostasis chain included: the "heparin-rebound" phenomenon (3.4%), activation of the secondary fibrinolysis (3.4%) and disseminated intravascular coagulation (DIC) (0.14%). Finally, an undiagnosed inadequate surgical hemostasis provoked an intense bleeding in 19.5% of cases.


Assuntos
Transtornos da Coagulação Sanguínea/complicações , Procedimentos Cirúrgicos Cardíacos , Circulação Extracorpórea , Hemostasia/fisiologia , Hemorragia Pós-Operatória/etiologia , Transtornos da Coagulação Sanguínea/sangue , Fatores de Coagulação Sanguínea/análise , Feminino , Humanos , Masculino , Hemorragia Pós-Operatória/sangue , Estudos Retrospectivos
19.
Anesteziol Reanimatol ; (5): 20-2, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15573719

RESUMO

The paper represents data on the condition of the hemostasis of plasma and platelet chains as well as of the system of natural anticoagulants and fibrinolysis as observed in cardiosurgical patients after mini-invasion coronary artery bypass surgery. An intensified generation of platelets, postoperative hyperaggregation of platelets and a lower level of natural anticoagulants in blood were shown as to be compensated for by an activated system of fibrinolysis.


Assuntos
Inibidores dos Fatores de Coagulação Sanguínea/análise , Fatores de Coagulação Sanguínea/análise , Ponte de Artéria Coronária , Hemostasia/fisiologia , Feminino , Humanos , Período Intraoperatório , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA